|
10123
|
SA14-14-2 (IXIARO)
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Sanofi Pasteur
|
2013
|
Thailand
|
NA
|
NA
|
Subcutaneous
|
NA
|
SA 14-14-2
|
Cell culture based
|
NA
|
NA
|
NA
|
NA
|
24161909
|
NCT01092507
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://www.fda.gov/media/75777/download
|
|
10124
|
ENCEVAC
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Research Foundation for Microbial Diseases of Osaka University
|
NA
|
NA
|
NA
|
NA
|
Subcutaneous
|
NA
|
Beijing-1(P1)
|
Cell culture based
|
NA
|
NA
|
NA
|
JEBIK V (BIKEN), KD-287, JEIMMUGEN INJ (Kaketsuken)
|
24161909
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://ifli.wisc.edu/wp-content/uploads/sites/528/2019/05/Japanese-Encephalitis.pdf
|
|
10125
|
IXIARO
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Valneva
|
NA
|
UK
|
2 months and above
|
2 doses 28 days apart
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
Beijing-3(P3), SA14-14-2
|
Cell culture based
|
US FDA
|
NA
|
New Zealand, Europe, India, China, US, Japan
|
IC51, JESPECT, JEEV (Intercell AG) in Australia
|
24161909
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/ixiaro
|
|
10126
|
IMOJEV
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Sanofi Pasteur
|
2017
|
Thailand
|
9 months and above
|
3 doses
|
Subcutaneous
|
NA
|
SA 14-14-2
|
Mouse brain based
|
US FDA
|
NA
|
NA
|
ChimeriVax-JE, JE-CV, THAIJEV (Sanofi-Aventis)
|
24161909
|
NCT01900444
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/japanese-encephalitis-vaccine-inactivated-adsorbed
|
|
10370
|
JE-VAX
|
Viral encephalitis
|
Neurologic
|
West Nile virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Phase 3
|
Research Foundation for Microbial Diseases of Osaka University
|
NA
|
China
|
NA
|
NA
|
Subcutaneous
|
NA
|
Nakayama-NIH/Beijing-1(P1) strain
|
Mouse brain based
|
NA
|
NA
|
Asia
|
SA 14-14-2 vaccine
|
24161909
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/
|
NA
|